These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38480668)
1. Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Romito O; Lemettre A; Chantôme A; Champion O; Couty N; Ouldamer L; Hempel N; Trebak M; Goupille C; Potier-Cartereau M Mol Oncol; 2024 Aug; 18(8):1853-1865. PubMed ID: 38480668 [TBL] [Abstract][Full Text] [Related]
2. Small-conductance Ca2+-activated potassium type 2 channels regulate the formation of contextual fear memory. Murthy SR; Sherrin T; Jansen C; Nijholt I; Robles M; Dolga AM; Andreotti N; Sabatier JM; Knaus HG; Penner R; Todorovic C; Blank T PLoS One; 2015; 10(5):e0127264. PubMed ID: 25938421 [TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells. Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274 [TBL] [Abstract][Full Text] [Related]
4. Functional interaction of Junctophilin 2 with small- conductance Ca Fan HK; Luo TX; Zhao WD; Mu YH; Yang Y; Guo WJ; Tu HY; Zhang Q Acta Physiol (Oxf); 2018 Mar; 222(3):. PubMed ID: 29055091 [TBL] [Abstract][Full Text] [Related]
5. The MORN domain of Junctophilin2 regulates functional interactions with small-conductance Ca Luo T; Li L; Peng Y; Xie R; Yan N; Fan H; Zhang Q Biofactors; 2021 Jan; 47(1):69-79. PubMed ID: 31904168 [TBL] [Abstract][Full Text] [Related]
6. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target. Wang H; Ye F; Zhou C; Cheng Q; Chen H PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867 [TBL] [Abstract][Full Text] [Related]
7. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism. Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320 [TBL] [Abstract][Full Text] [Related]
8. Identification of SK3 channel as a new mediator of breast cancer cell migration. Potier M; Joulin V; Roger S; Besson P; Jourdan ML; Leguennec JY; Bougnoux P; Vandier C Mol Cancer Ther; 2006 Nov; 5(11):2946-53. PubMed ID: 17121942 [TBL] [Abstract][Full Text] [Related]
9. Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain. Willis M; Trieb M; Leitner I; Wietzorrek G; Marksteiner J; Knaus HG Brain Struct Funct; 2017 Mar; 222(2):973-979. PubMed ID: 27357310 [TBL] [Abstract][Full Text] [Related]
13. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study. Yu X; Zhang Y; Chen H BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800 [TBL] [Abstract][Full Text] [Related]
14. The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine. Potier M; Chantome A; Joulin V; Girault A; Roger S; Besson P; Jourdan ML; LeGuennec JY; Bougnoux P; Vandier C Br J Pharmacol; 2011 Jan; 162(2):464-79. PubMed ID: 20955368 [TBL] [Abstract][Full Text] [Related]
15. Functional interaction with filamin A and intracellular Ca2+ enhance the surface membrane expression of a small-conductance Ca2+-activated K+ (SK2) channel. Rafizadeh S; Zhang Z; Woltz RL; Kim HJ; Myers RE; Lu L; Tuteja D; Singapuri A; Bigdeli AA; Harchache SB; Knowlton AA; Yarov-Yarovoy V; Yamoah EN; Chiamvimonvat N Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9989-94. PubMed ID: 24951510 [TBL] [Abstract][Full Text] [Related]
16. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607 [TBL] [Abstract][Full Text] [Related]
17. Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders. Mochel F; Rastetter A; Ceulemans B; Platzer K; Yang S; Shinde DN; Helbig KL; Lopergolo D; Mari F; Renieri A; Benetti E; Canitano R; Waisfisz Q; Plomp AS; Huisman SA; Wilson GN; Cathey SS; Louie RJ; Gaudio DD; Waggoner D; Kacker S; Nugent KM; Roeder ER; Bruel AL; Thevenon J; Ehmke N; Horn D; Holtgrewe M; Kaiser FJ; Kamphausen SB; Abou Jamra R; Weckhuysen S; Dalle C; Depienne C Brain; 2020 Dec; 143(12):3564-3573. PubMed ID: 33242881 [TBL] [Abstract][Full Text] [Related]
18. Ondansetron blocks wild-type and p.F503L variant small-conductance Ca Ko JS; Guo S; Hassel J; Celestino-Soper P; Lynnes TC; Tisdale JE; Zheng JJ; Taylor SE; Foroud T; Murray MD; Kovacs RJ; Li X; Lin SF; Chen Z; Vatta M; Chen PS; Rubart M Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H375-H388. PubMed ID: 29677462 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of two blockers of small conductance Ca2+-activated K+ channels, apamin and lei-Dab7, on learning and memory in rats. Mpari B; Regaya I; Escoffier G; Mourre C J Integr Neurosci; 2005 Sep; 4(3):381-96. PubMed ID: 16178064 [TBL] [Abstract][Full Text] [Related]
20. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis. Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]